Pharmaceutical Industry Makes Steady Progress Toward Meeting 2023 DSCSA Interoperability Requirements
Pharmaceutical Industry Makes Steady Progress Toward Meeting 2023 DSCSA Interoperability Requirements 2020 Barcode Assessment Documents Year-Over-Year Improvements News provided by Share this article Share this article EWING, N.J., Feb. 8, 2021 /PRNewswire/ -- A new GS1 US Barcode Assessment study shows that the pharmaceutical industry is making continued, steady progress toward interoperability, with a growing majority of products now properly serialized according to 2013 Drug Supply Chain Security Act (DSCSA) requirements. Conducted in 2020 by AmerisourceBergen Corporation, McKesson Pharma...
Source: prnewswire.com